Advertisement
Table 2 Association between clinicopathological features and pCR in FEC-Taxotere treated group (N = 118)
| Total | pCR (N = 25) | No pCR (N = 93) | P value | |||
|---|---|---|---|---|---|---|
| N = 118 | n | %a | n | %a | ||
| Tumor size | ||||||
| T0-T1 | 5 | 1 | 20.0 | 4 | 80.0 | |
| T2 | 60 | 16 | 26.7 | 44 | 73.3 | |
| T3 | 24 | 3 | 12.5 | 21 | 87.5 | |
| T4 | 27 | 4 | 14.8 | 23 | 85.2 | NS† |
| NA | 2 | 1 | 1 | |||
| Histopronostic grade | ||||||
| SBRI–SBRII | 61 | 9 | 14.8 | 52 | 85.2 | |
| SBRIII | 43 | 16 | 37.2 | 27 | 62.8 | 0.009* |
| NA | 14 | 0 | 14 | |||
| Nodal status | ||||||
| Positive | 63 | 12 | 19.1 | 51 | 80.9 | |
| Negative | 53 | 12 | 22.6 | 41 | 77.4 | NS† |
| NA | 2 | 1 | 1 | |||
| KI67 | ||||||
| Positive | 42 | 12 | 28.6 | 30 | 71.4 | |
| Negative | 6 | 0 | 0.0 | 6 | 100.0 | NS† |
| NA | 70 | 13 | 57 | |||
| Hormone receptor status | ||||||
| RH | ||||||
| Positiveb | 77 | 12 | 15.6 | 65 | 84.4 | |
| Negativec | 39 | 13 | 33.3 | 26 | 66.7 | 0.003* |
| NA | 2 | 0 | 2 | |||
| RE | ||||||
| Positive | 74 | 10 | 13.5 | 64 | 86.5 | |
| Negative | 42 | 15 | 35.7 | 27 | 64.3 | 0.005* |
| NA | 2 | 0 | 2 | |||
| RP | ||||||
| Positive | 57 | 10 | 17.5 | 47 | 82.5 | |
| Negative | 58 | 15 | 25.9 | 43 | 74.1 | NS* |
| NA | 3 | 0 | 3 | |||
| Triple negative | ||||||
| Yes | 32 | 13 | 40.6 | 19 | 59.4 | |
| No | 75 | 12 | 16.0 | 63 | 84.0 | 0.006* |
| NA | 11 | 0 | 11 | |||
